Abstract Although Chronic Myeloid Leukaemia (CML) can be treated successfully with
allogeneic bone marrow transplantation (BMT), leukaemia relapse remains a significant …

Chronic myeloid leukaemia (CML) can be treated successfully with allogeneic bone marrow
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …

Determination of hematological chimerism could be helpful in understanding the biology of
leukemic relapse after allogeneic bone marrow transplant (BMT) for chronic myeloid …

We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …

Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …

Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

In the prospective study, we examined hematopoietic mixed chimerism (using polymerase
chain reaction (PCR) of variable number of tandem repeat-VNTR sequences) and minimal …

The detection of chimerism, residual molecular and cytogenetic disease following
transplantation of peripheral blood stem cells (PBSCT) with a nonmyeloablative conditioning …

Patients that receive a T-cell depleted (TCD) hematopoietic stem cell transplantation (SCT)
show higher risk of graft failure/rejection and of disease relapse than those that receive …

A second bone marrow transplant (BMT) might be considered as an option in patients with
leukaemia with graft failure after BMT. We report the successful treatment of a patient with …